Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial.
Publication/Presentation Date
8-1-2020
Volume
17
Issue
8
First Page
998
Last Page
1007
ISSN
2325-6621
Published In/Presented At
Weaver, T. E., Drake, C. L., Benes, H., Stern, T., Maynard, J., Thein, S. G., Andry, J. M., Sr, Hudson, J. D., Chen, D., Carter, L. P., Bron, M., Lee, L., Black, J., & Bogan, R. K. (2020). Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial. Annals of the American Thoracic Society, 17(8), 998–1007. https://doi.org/10.1513/AnnalsATS.202002-136OC
Disciplines
Medicine and Health Sciences
PubMedID
32353246
Department(s)
Department of Medicine
Document Type
Article
COinS